Patients with cystic fibrosis (CF) suffer from chronic respiratory infections, primarily caused by Pseudomonas aeruginosa, which lead to airway inflammation and damage. Several recent studies have suggested that a specific ...
Jul 21, 2016
0
1
(HealthDay)—For patients with cystic fibrosis (CF), early treatment of Pseudomonas aeruginosa (Pa) may be beneficial, according to a study published online June 16 in the Journal of Clinical Pharmacy and Therapeutics.
Jun 23, 2016
0
0
The lungs contain a thin layer of fluid known as the airway surface liquid (ASL), which helps protect against pathogens. The appropriate ASL volume, pH, and ionic composition are required for optimal airway defense. Cystic ...
Jun 2, 2016
0
1
In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.
May 25, 2016
0
2
Scientists at Queen's University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
May 12, 2016
0
568
A new study led by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) and Cystic Fibrosis Canada reinforces the benefits of newborn screening for cystic fibrosis (CF) patients. Despite the ...
May 5, 2016
0
3
Scientists said Monday they had found a handful of healthy people each carrying a genetic mutation that should have condemned them to crippling disease or death.
Apr 11, 2016
1
90
Cystic fibrosis (CF) is caused by mutations in the chloride channel CFTR, which disrupts fluid transport in the lungs. CF patients have a variety of complications, including airway obstruction, infection, and pathological ...
Apr 7, 2016
0
0
UT Southwestern Medical Center researchers have discovered a mutation that causes a rare systemic disorder known as X-linked reticulate pigmentary disorder (XLPDR) and, significantly, the unexpected cellular mechanism by ...
Mar 28, 2016
0
54
(HealthDay)—Guidelines have been developed for the care of 2- to 5-year-old children with cystic fibrosis (CF). The clinical practice guidelines were published online March 23 in Pediatrics.
Mar 24, 2016
0
3
